Trials / Completed
CompletedNCT01424280
Single Dose Study of GSK1440115 in Patients With Asthma
A Phase 1, Randomized, Placebo Controlled, Crossover Study to Evaluate the Efficacy of GSK1440115 After a Single Oral Dose in Patients With Asthma
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Accenture · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess bronchodilator effect after single dose administration of GSK1440115 in a population of mild to moderate asthmatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1440115 | Single dose of either 750 mg or 500 mg administered as 250 mg tablets. |
| DRUG | Placebo | Single dose of matching placebo tablets |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-11-01
- First posted
- 2011-08-26
- Last updated
- 2011-12-02
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01424280. Inclusion in this directory is not an endorsement.